What's trending

5 most popular innovation stories in Houston this week

Sesh Coworking launches virtual platform, flood damage-preventing startups pitch, and more make this week's roundup of top news stories. Photo courtesy of Sesh Coworking

Editor's note: People drive innovation in Houston, and that's been true more than ever amid the COVID-19 pandemic. This week's roundup of top news on InnovationMap also reflects that, from innovators to know, Q&As with local entrepreneurs, and more.

3 Houston innovators to know this week

This week's Houston innovators to know includes Rebecca Vaught of Van Heron Labs, Samantha Lewis of GOOSE Capital, and Camilo Mejia of Enovate Upstream. Courtesy photos

Houston entrepreneurs are like the city itself — resilient. And much like the wildcatters that preceded them, they are self-starters and hard working. This week's roundup of Houston innovators all reflect these attributes — whether they're founding their company amid a global pandemic or rebranding a 15-year-old investing institution. Continue reading.

Flood-focused startups pitch at virtual event held by Houston's new resiliency innovation hub

These three startups are innovating flood damage mitigation tools so that Houstonians can have peace of mind this hurricane season. Getty Images

In light of Houston's frequent floods, a local organization has formed to encourage innovation in resiliency — especially as the city moves throughout the 2020 hurricane season.

The Gulf Coast & Southwest Resilience Innovation Hub was founded last month by the Insurance Information Institute and ResilientH20 Partners in The Cannon's downtown location. The organization is looking into the best innovations within resiliency — especially as it pertains to Houston, where nine of the 10 most expensive hurricanes in the United States have occurred in the past 16 years.

"There has been a widespread interest in, and demand for, best-in-class actionable, alternative disaster mitigation solutions since 2017's Hurricane Harvey and subsequent storms caused extensive insured losses to autos, homes, businesses, and governmental properties," says Richard Seline, managing partner of ResilientH2O Partners, in a news release. Continue reading.

Houston coworking company launches online portal to connect members working from home

Houston-based Sesh Coworking has launched an online platform so that members can work alongside each other. Photo via seshcoworking.com

As the COVID-19 pandemic continued to enforce working from home and social distancing earlier this summer, a Houston coworking company knew they needed to find a way to reach professionals and entrepreneurs digitally.

Sesh Coworking launched its Inner Circle membership this week to be a one-stop shop for business, connection, support, and more for members. Last month, Meredith Wheeler and Maggie Segrich began working on the virtual space after discovering the need for this virtual space from their network.

"We talked to a lot of people," Wheeler tells InnovationMap. "We were constantly asking people, 'what do you need right now?' And the resounding answer was for community and connection." Continue reading.

This Houston startup is increasing access to marketing for other startups and small businesses

"We're here for the founders and the little guys," Alfredo Arvide says about his new venture that's redefining marketing for small businesses and startups. Photo courtesy of MAP360

A new Houston organization is working to redefine the way startups set up their marketing strategy — focusing on specific projects tailored to the client's goals at a significantly cheaper price than a normal marketing agency.

MAP360, also known as The Marketing Acceleration Program, is collaborating one-on-one with clients to learn their particular needs and goals for individual projects. Unlike traditional marketing agencies, they do not work on retainer, instead they focus on small contracts to increase efficiency and affordability for startups and small businesses.

"There is a great opportunity in Houston with the accelerating innovation ecosystem," says Alfredo Arvide, CEO and co-founder. "When my co-founder and I were brainstorming ideas, we saw the need for a marketing program tailored specifically for startups or small businesses." Continue reading.

Houston venture capital group enters into new era with rebrand

Samantha Lewis, director of GOOSE Capital, shares how the investment firm has rebranded and is focused on the future. Photo courtesy of GOOSE

A Houston-based venture group has flipped the switch on its rebranding in order to transition itself into a new era of innovation and startup investing.

GOOSE Capital — previously known as GOOSE Society of Texas — is a private investment firm based in Houston that focuses on early-stage venture capital deals. Rather than operating as a fund, the GOOSE Capital model enables its corps of investors comprised of Fortune 500 execs and successful serial entrepreneurs direct access to a portfolio of startups and investment deals. At the same time, GOOSE's portfolio companies are able to receive support from these investors. Continue reading.

Trending News

 
 

Promoted

A research team housed out of the newly launched Rice Biotech Launch Pad received funding to scale tech that could slash cancer deaths in half. Photo via Rice University

A research funding agency has deployed capital into a team at Rice University that's working to develop a technology that could cut cancer-related deaths in half.

Rice researchers received $45 million from the National Institutes of Health's Advanced Research Projects Agency for Health, or ARPA-H, to scale up development of a sense-and-respond implant technology. Rice bioengineer Omid Veiseh leads the team developing the technology as principal investigator.

“Instead of tethering patients to hospital beds, IV bags and external monitors, we’ll use a minimally invasive procedure to implant a small device that continuously monitors their cancer and adjusts their immunotherapy dose in real time,” he says in a news release. “This kind of ‘closed-loop therapy’ has been used for managing diabetes, where you have a glucose monitor that continuously talks to an insulin pump. But for cancer immunotherapy, it’s revolutionary.”

Joining Veiseh on the 19-person research project named THOR, which stands for “targeted hybrid oncotherapeutic regulation,” is Amir Jazaeri, co-PI and professor of gynecologic oncology at the University of Texas MD Anderson Cancer Center. The device they are developing is called HAMMR, or hybrid advanced molecular manufacturing regulator.

“Cancer cells are continually evolving and adapting to therapy. However, currently available diagnostic tools, including radiologic tests, blood assays and biopsies, provide very infrequent and limited snapshots of this dynamic process," Jazaeri adds. "As a result, today’s therapies treat cancer as if it were a static disease. We believe THOR could transform the status quo by providing real-time data from the tumor environment that can in turn guide more effective and tumor-informed novel therapies.”

With a national team of engineers, physicians, and experts across synthetic biology, materials science, immunology, oncology, and more, the team will receive its funding through the Rice Biotech Launch Pad, a newly launched initiative led by Veiseh that exists to help life-saving medical innovation scale quickly.

"Rice is proud to be the recipient of the second major funding award from the ARPA-H, a new funding agency established last year to support research that catalyzes health breakthroughs," Rice President Reginald DesRoches says. "The research Rice bioengineer Omid Veiseh is doing in leading this team is truly groundbreaking and could potentially save hundreds of thousands of lives each year. This is the type of research that makes a significant impact on the world.”

The initial focus of the technology will be on ovarian cancer, and this funding agreement includes a first-phase clinical trial of HAMMR for the treatment of recurrent ovarian cancer that's expected to take place in the fourth year of THOR’s multi-year project.

“The technology is broadly applicable for peritoneal cancers that affect the pancreas, liver, lungs and other organs,” Veiseh says. “The first clinical trial will focus on refractory recurrent ovarian cancer, and the benefit of that is that we have an ongoing trial for ovarian cancer with our encapsulated cytokine ‘drug factory’ technology. We'll be able to build on that experience. We have already demonstrated a unique model to go from concept to clinical trial within five years, and HAMMR is the next iteration of that approach.”

Trending News

 
 

Promoted